News in Numbers

10

The US Department of Health and Human Services (HHS) released a list of the first ten drugs that will be up for price negotiations with the Centers for Medicare & Medicaid Services (CMS).

$760 m

The Remote Patient Monitoring (RPM) market is steadily growing, and expected to be worth $760 million by 2030, as per a recent GlobalData report.

22

As per 2022 US population data, adult obesity prevalence is at 35% or higher in 22 states, which is an increase compared to 19 states the previous year.

800 m

The Biden administration has submitted a supplemental funding request of $800 million to the US Congress to combat the fentanyl crisis.

55

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has delivered 55 positive opinions on new medicines in 2023, as per a September update.

Go to article: Home | How pharma wants to break the efficacy ceiling in IBDGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: UrsatecGo to article: SHL Medical Company InsightGo to article: SHL MedicalGo to article: ControlantGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article:  Sensified.ioGo to article: In DepthGo to article: How pharma wants to break the efficacy ceiling in IBDGo to article: Subcutaneous drugs grant a new lease on life to checkpoint inhibitorsGo to article: Hope for the UK clinical trial landscape but it requires a lot of work Go to article: Novo Nordisk’s Wegovy to start being supplied by NHS in EnglandGo to article: Minimal impact expected for first ten drugs released for Medicare price negotiationGo to article: Q&A: Human touch remains critical for the patient experience in trialsGo to article: Zenatek Company InsightGo to article: BEA TechnologiesGo to article: ListingsGo to article: EventsGo to article: AwardsGo to article: Buyer's GuidesGo to article: Next issue